Stockreport

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, [Read more]